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           Notch signaling regulates a wide range of cel-
lular developmental and activation events in 
multicelled organisms ( 1  –  6  ). There are four mam-
malian Notch receptors (Notch1  –  4) that appear 
to activate a common pathway. Upon binding 
to Jagged or Delta-like (dll) ligands on a neigh-
boring cell, proteolysis by      secretase releases 
the intracellular domain of Notch, and it is 
translocated to the nucleus, where it converts 
the transcription factor CSL/RBP-J from a tran-
scriptional repressor to an activator. In the nu-
cleus, Mastermind-like (MAML) proteins bind 
the Notch  –  CSL/RBP-J complex and act as a 
platform to recruit coactivators (  2, 7, 8  ). MAML 
is required for CSL/RBP-J  –  dependent Notch 
signaling, and inhibiting the ability of MAML 
proteins to recruit coactivators blocks transcrip-
tional activation by Notch. In recent years, 
Notch-mediated responses have been shown to 
be involved in T cell lineage maturation from 
double-negative (DN) pro  –  T cells to double-
positive CD4/CD8  +   T cells in the thymus 
(  3, 9, 10  ). Studies have mapped out this latter 
mechanism in the thymus and help to explain 
how T cells develop through the early stages, 
whereas more recent studies have identifi  ed a 
complex relationship in mature peripheral T 
cells during antigen-specifi  c responses (  2, 7, 8  ). 
  In the mature immune system, the Notch 
pathway has been described as a signaling mech-
anism involved in regulating cell lineage choices 
for T cells. Amsen et. al. demonstrated that 
MyD88-dependent Th1 stimuli up-regulate the 
Notch ligand dll4 in DCs and polarizes Th1 
cells, whereas MyD88-independent Th2 stimuli 
up-regulate the Notch ligand Jagged and polar-
ize Th2 cells (  11  ). The importance of Notch 
activation has been supported using a      secre-
tase inhibitor, which is a pharmacologic inhibi-
tor of Notch signaling pathways, to block the 
induction of Th1-type responses (  7, 12  ). How-
ever, with multiple Notch receptors on naive 
Th cells (Notch 1, 2, 3, 4) and ligands on DCs 
(dll1, dll4, Jagged1, and Jagged2), the inter-
actions are complex and still poorly understood. 
Others have suggested the Notch ligands may 
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RSV using the specifi  c antisera for dll4 demonstrated that this 
molecule was present on the surface of the cell after RSV 
infection (  Fig. 1 D  ). Similar to the RNA expression pattern 
observed in   Fig. 1 A  ,   Fig. 1 (C and D)   demonstrate that dll4 
protein was substantially increased on BMDCs after they were 
infected with RSV. 
  Specifi  c neutralization of dll4 during RSV infection induces 
airway hyperresponsiveness (AHR), increased tissue 
pathology, and Th2-type cytokines 
  Recent results have suggested that Notch ligands can diff  eren-
tially alter immune responses. In particular, dll4 was identifi  ed 
also play a role in the activation or inhibition of proliferation 
of T cells, which further underlies the complexity of these 
interactions. Several interesting and instructive studies have 
separately demonstrated that Notch activation is responsible 
for the generation of Th1, Th2, or T reg cell generation, sug-
gesting that the role of Notch activation pathways may be a 
contextual mechanism and depend on the immune environ-
ment (  11, 13  –  16  ). A recent study indicated that one aspect 
of Notch signaling may be to prolong survival of T cells by 
altering apoptotic processes (  17  ). The role of Notch in diff  er-
entiation of an immune response is relatively uncharacterized, 
and it may include roles in survival and diff  erentiation of a 
developing immune response. In this study, we have exam-
ined the role of   dll4   Notch ligand for the activation of the 
appropriate antiviral responses and examined it in relation-
ship to IL-12, which is a classic instructive immune signal. 
The link between IL-12 and Notch ligand instructive signal 
expression patterns on DCs has recently been established in 
respiratory syncytial virus (RSV) by our laboratory, using 
MyD88    −  /  −    mice, and the expression of the two are indepen-
dent of one another (  18  ). Overall, the role of   dll4   appears 
to be a regulating signal for Th2 cytokine production, as well 
as IFN     expression, and therefore   dll4   helps to maintain a 
Th1 environment. 
    RESULTS   
  RSV induces dll4 in DCs 
  The identifi  cation of Notch ligand expression during viral in-
fection provides initial data for justifying the role during disease. 
Freshly grown and isolated bone marrow  –  derived DCs 
(BMDCs) were infected with RSV (multiplicity of infection 
[MOI] = 1.0) and assessed for Notch ligand mRNA expression 
by quantitative PCR analyses (  Fig. 1 A  ).   The data indicates 
that, compared with uninfected DCs, RSV primarily induces 
the up-regulation of dll4 and causes little increase in the other 
Notch ligands, including dll1, dll3, Jagged1, and Jagged2, 
in BMDC populations (unpublished data) (  18  ). To confi  rm 
previously published data that this up-regulation was MyD88 
dependent, we compared the expression of dll4   during RSV 
infection in GM-CSF  –  grown BMDCs from MyD88     −  /  −    mice 
and found no increase in dll4 expression when MyD88 was 
absent (  Fig. 1 A  ). This result was also verifi  ed using a CpG/
Toll-like receptor (TLR) 9 stimulus that specifi  cally functions 
through MyD88. Thus, RSV specifi  cally up-regulates dll4, 
but not other Notch ligands, and it is dependent on MyD88 
activation pathways. 
  After identifying that dll4 was the predominant ligand 
up-regulated by RSV infection, we generated a polyclonal 
rabbit anti  –  mouse antibody to dll4 using previously published 
protocols (  19, 20  ). The specifi  city of this antibody was veri-
fi  ed by using stably transfected OP-9 cell lines for Notch li-
gands Dll1, Dll4, and Jagged1, and the sera was found only to 
react with the cell line expressing dll4 (  Fig. 1 B  ). The expres-
sion of dll4 protein on BMDCs was then assessed by Western 
blot analysis using cell lysates from BMDCs infected with 
RSV (  Fig. 1 C  ). Flow cytometry of BMDCs infected with 
  Figure 1.     dll4 up-regulation on DCs is MyD88 dependent, and 
occurs upon RSV infection. (A) BMDCs from wild-type or MyD88   − / −   
mice were cultured for 6 h in the presence of CpG or RSV for 6 h. Fold 
increase in dll4 expression was determined by comparison to an unstimu-
lated culture. *, P   <   0.01 compared with cells from MyD88   − / −    mice. 
(B) Western blot demonstrating the specifi  city of our polyclonal dll4 antibody 
by using OP9 cells transfected with various Notch ligands. (C) Western 
blot demonstrating that dll4 is up-regulated on BMDCs after RSV infec-
tion. No nonspecifi  c bands were observed on either of our blots after 
incubation with our polyclonal anti-dll4 antibody. (D) BMDCs from wild-
type mice were stimulated with RSV for 24 h. Flow cytometry was per-
formed using a specifi  c polyclonal antibody to dll4. Error bars represent 
the mean   ±   the SEM.     JEM VOL. 204, November 26, 2007 
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only during the initial phase of the viral infection or for the 
entire length of the immune response, we used a delayed 
  administration of anti-dll4 antibody that began 4 d after in-
fection, and compared mice receiving control serum or dll4 
blockade from day 0 of infection. 8 d after infection, mice 
receiving delayed administration of dll4 antibody demon-
strated an intermediate phenotype between those mice re-
ceiving control serum or dll4 blockade for the duration of 
the experiment. AHR readings from mice given anti-dll4 the 
entire time induced a 4-fold increase, whereas delayed anti-
dll4 treatment induced a 2.5-fold increase over control IgG-
treated animals after RSV infection. IL-13 mRNA expression 
levels in the lymph nodes were also examined. Compared 
with control mice anti-dll4 treatment for the entire RSV in-
fection induced a 7.0   ±   1.2-fold increase, whereas delayed 
anti-dll4 induced a 1.64   ±   0.1-fold increase over control IgG 
treatment. These data indicate that dll4 is required to be pre-
sent for the entire response, and not just during the initial 
viral infection. 
as an important factor for skewing T cells toward a type I im-
mune response. To test this hypothesis, animals were infected 
with RSV and treated with either the anti-  dll4   or control 
  antibody on day 0, 2, 4, and 6 of infection. Comparatively, a 
second group of animals were treated with anti  –  IL-12, which 
is an important factor in eliciting Th1 responses from T cells. 
We have previously shown that treatment with this antibody 
during RSV infection increases the pathology of RSV-in-
duced disease. Animals were assessed for multiple parameters 
on day 8 of infection. In   Fig. 2 A  , we show that both anti  –  IL-12 
and anti-dll4 treatment signifi  cantly increase airway hyper-
reactivity of mice 8 d after RSV infection compared with controls.  
To assess the immunologic mechanism through which increases 
in AHR occurred, mRNA from draining lymph nodes of 
mice 8 d after RSV infection was analyzed for cytokine 
  expression. Although anti  –  IL-12 reduced the expression of 
IFN     by     40%, the treatment did not have any eff  ect on the 
levels of Th2 cytokines expressed in draining lymph nodes. 
In contrast, the treatment of mice with anti-dll4 led to 
  increases in the Th2 cytokines IL-5 (8.5-fold) and -13 (4-fold) 
compared with control mice (  Fig. 2 B  ). Thus, the initial stud-
ies comparing the role of these two instructive signals dem-
onstrate a similar clinical outcome potentially resulting from 
a diff  erent cytokine profi  le. To determine if dll4 was required 
  Figure 2.     Blockade of dll4 increases airway hyperreactivity and 
lymph node cytokines. (A) RSV-infected mice were treated on day 0, 2, 
4, and 6 with antibody to either dll4 or IL-12. AHR was assessed 8 d after 
infection. *, P   <   0.05 compared with uninfected; **, P   <   0.001 compared 
with control-treated and infected mice. (B) Lymph nodes were isolated 
from mice subjected to the same treatments as in A. Quantitative real-
time PCR was performed on lymph node mRNA for the cytokines IFN   , 
IL-13, -5, and -4. *, P   <   0.01 compared with control and anti  –  IL-12. 
**, P   <   0.001 compared with control and anti  –  IL-12. Error bars represent 
the mean   ±   the SEM.     
  Figure 3.     dll4 blockade drives mucus expression in the lung. (A) Lungs 
from mice receiving Dll4 blockade were taken 8 d after RSV infection and 
assayed for mucus production by performing quantitative real-time PCR 
for the mucus gene GOB5. *, P = 0.02 compared with control. (B) Enumeration 
of peribronchial eosinophils by morphometric analysis of hemotoxylin and 
eosin  –  stained lung sections from control antibody or anti-dll4  –  treated 
animals after 12 d of RSV infection. Data represents the mean   ±   the SEM 
from three mice. *, P = 0.015. (C) periodic acid Schiff staining of formalin-
fi  xed sections of lung showing the amount of mucus in the airways of 
control-treated and anti  –  Dll4  –  treated animals 12 d after RSV infection. 
Bars, 500    m.   2928 DELTA-LIKE 4 IN RESPIRATORY VIRAL INFECTION | Schaller et al.
strated in   Fig. 4 A  , there were signifi  cantly more total CD4  +   
T cells in the anti-dll4  –  treated animals compared to animals 
treated with control sera.   Additionally, substantially more 
CD4  +   T cells expressing the very early activation marker 
CD69 were found in the lungs of mice receiving dll4 block-
ade, suggesting that these cells were activated (  Fig. 4 B  ). The 
total number of CD8  +   T cells was also increased in the lungs 
of mice receiving anti-dll4 treatment (  Fig. 4 C  ), as was the 
number of perforin  +  CD8  +   T cells, indicating that these cells 
had also been activated. These data further imply that anti-dll4 
blockade notably alters the immune environment of the lung. 
We also quantifi  ed the number of T cells in the draining lymph 
nodes of anti-dll4  –  treated mice. In contrast to our fi  ndings in 
the lung, we observed a substantial decrease in the number 
of CD4  +   T cells in the lymph nodes of anti-dll4  –  treated mice. 
There appeared to be a decrease in the total number of CD8  +   
T cells, whereas the number of perforin  +  CD8  +   T cells in the 
draining lymph nodes remained the same regardless of the 
  absence of dll4. Given the aforementioned changes, separate 
studies examined viral clearance by performing plaque assays 
using the lungs of animals at 2, 4, and 5 d after RSV infection 
with specifi  c anti-RSV antibodies to identify positive plaques 
in culture. No signifi  cant alteration in the viral clearance was 
observed in the anti-dll4  –  treated compared with control mice 
at any time point (D2 wild-type, 53   ±   1 pfu/g lung; anti-dll4, 
95   ±   7 pfu/g lung; D4 wild-type, 3,609   ±   430 pfu/g lung; and 
anti-dll4, 1,578   ±   205 pfu/g lung). 
  To further characterize the changes that occurred in vivo 
during the blockade of   dll4  , the production of Th1 and Th2 
  Mucus overproduction is one of the hallmarks of severe 
RSV-induced disease in infants. Examination of the mucus-
associated gene gob5 in anti-dll4  –  treated animals demon-
strated a substantial increase in expression compared with the 
control antibody-treated animals (  Fig. 3 A  ).   Several investigators 
have found RSV to be associated with increased pulmonary 
pathology, mucus hypersecretion, and eosinophil   recruitment 
to the airways. Enumeration of peribronchial eosinophils 
  associated with major airways revealed that although RSV-
infected mice do not normally have signifi  cant numbers of 
eosinophils within or around their airways, animals treated 
with anti-dll4 displayed signifi  cant increases in eosinophil 
  accumulation (  Fig. 3 B  ). However, the majority of the infi  l-
trating cells around the airway were mononuclear. Histologic 
examination of the lungs of mice 12 d after RSV infection 
that had received dll4 blockade demonstrated increased in-
fl  ammatory cell infi  ltrate and goblet cell development, indi-
cating a substantial change in the overall immune response 
(  Fig. 3 C  ). In fact, as indicated by the histology, many of the 
airways were completely congested with mucus in the anti-
dll4  –  treated animals. Thus, dll4 appears to provide signals that 
prevent the development of severe physiologic changes in the 
lung during RSV infection. 
  To further characterize the eff  ect of the dll4 blockade dur-
ing RSV infection, we enumerated T cells in the lung and 
draining lymph nodes of control and anti-dll4  –  treated mice 
8 d after RSV infection by fl  ow cytometry. There were notable 
changes in T cell subset numbers in both the lung and lymph 
node of mice receiving the dll4-specifi  c antibody. As demon-
  Figure 4.     The absence of dll4 alters the number and activation of T cells in the lung and lymph nodes of RSV-infected mice. Flow cytometry 
was performed using whole-lung digests or dispersed lymph nodes taken from mice 8 d after RSV infection. (A) The total number of CD4  +   T cells in the 
lung and lymph node. *, P = 0.0134 for lung and 0.0042 for lymph node. (B) The number of CD4  + CD69 +   T cells in the lung and lymph node. *, P = 0.0065 
for lung and 0.0020 for lymph node. (C) The total number of CD8  +   T cells in the lung and lymph node. *, P = 0.0349 for lung and 0.0113 for lymph node. 
(D) The number of CD8  + perforin +   cells in the lung and lymph node. *, P = 0.02. Error bars represent the mean   ±   the SEM.     JEM VOL. 204, November 26, 2007 
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lymph nodes with RSV-pulsed BMDCs, as described in the 
previous paragraph. We found that lymph node CD8  +   T cells 
from mice receiving anti-dll4 blockade produced a level of 
IFN     similar to those from CD8  +   T cells from control-treated 
mice (  Fig. 5 B  ). Interestingly, the CD8  +   T cells isolated from 
the lungs of anti-Dll4  –  treated mice produced substantially more 
IFN     and Th2 cytokines IL-13 and -5 than CD8  +   T cells iso-
lated from control-treated mice (  Fig. 5 D  ). 
  Dll4 regulates activation of Th2 cytokines and IFN 
during immune responses 
  To further examine the distinct role that dll4 and IL-12 have 
in the generation of the immune response, we used BMDCs 
grown from MyD88    −  /  −    mice that do not express either IL-12 
or dll4 after RSV infection (  18  ). For these experiments, 
we again used T cells cocultured with BMDCs, as previously 
described. In these experiments, CD4  +   T cells were isolated 
from the draining lymph nodes of RSV-infected wild-type 
or MyD88    −  /  −    mice 8 d after infection and cocultured with 
RSV-pulsed wild-type or MyD88    −  /  −    BMDCs. T cell cocul-
tures also contained 10     g/ml plate-coated recombinant dll4, 
10 ng/ml rIL-12, or a combination of both. The data   illustrate 
cytokines of treated mice was assessed after in vitro rechallenge 
with RSV. In these experiments CD4  +   T cells from the lungs 
or draining lymph nodes of RSV-infected mice were isolated 
using a magnetic bead column and exposed to RSV-pulsed 
BMDCs for 48 h. The BMDCs were grown in GM-CSF for 
6 d and purifi  ed so that   >  95% of the cells were CD11c  +  . These 
cells were infected with RSV (MOI = 1.0) for 2 h and washed 
before adding the T cells. Cytokine levels were measured 
  using bioplex proteomic assays (  Fig. 5, A and C  ).   The data illus-
trate that there were considerable decreases in IFN     production 
from T cells isolated from the lymph nodes of anti-dll4  –  treated 
animals compared with those from the control antibody-
treated animals (  Fig. 5 A  ). Additionally, the Th2 cytokines 
IL-4, -5, and -13 were signifi  cantly up-regulated in the anti-
dll4  –  treated animals compared with control antibody  –  treated 
and infected animals. A similar cytokine profi  le was observed 
using CD4  +   T cells isolated from the lung (  Fig. 5 C  ). These 
data suggest that the blockade of the dll4 signal altered the cyto-
kine profi  le of RSV-responsive T cells. 
  To assess the CD8  +   T cell aff  ect that was identifi  ed by in-
creased activated CD8  +   T cells in the lung and lymph node, 
we cultured CD8  +   T cells isolated from both lung and draining 
  Figure 5.     Cytokine profi  le of T cells is altered in the absence of dll4. CD4  +   and  CD8 +   T cells were isolated from the lymph nodes or lungs of control 
or anti  –  Dll4  –  treated mice and restimulated in vitro with RSV-pulsed BMDCs for 48 h. Cytokine levels were measured using a luminex system. (A) Lymph 
node CD4  +   T cell cytokine production after restimulation. *, P = 0.02 for IFN    , 0.005 for IL-13, 0.002 for IL-5, and 0.02 for IL-4. (B) Lymph node CD8  +   T  cell 
cytokine production after restimulation. (C) Lung CD4  +   T cell cytokine profi  le after restimulation. *, P = 0.0137 for IL-4 and 0.0150 for IL-13. (D) Lung CD8  +  
T cell cytokine profi  le after restimulation. *, P = 0.0007 for IFN    , 0.003 for IL-13, and 0.0150 for IL-5. Error bars represent the mean   ±   the SEM.     2930 DELTA-LIKE 4 IN RESPIRATORY VIRAL INFECTION | Schaller et al.
several important and novel fi  ndings regarding the potential 
individual roles for these two instructive signals (  Fig. 6  ).   First, 
when examining the ability of these two molecules to diff  er-
entially block the enhanced Th2 cytokine production by 
CD4  +   T cells, dll4 was able to considerably reduce the amount 
of IL-13 and -4 produced from MyD88    −  /  −    CD4  +   T cells re-
stimulated with RSV when compared with control cultures. 
A combination of these two signals produced the most strik-
ing reduction in Th2 cytokine levels, suggesting that the 
presence of both signals is necessary for the most appropriate 
T cell cytokine production in response to viral infection. 
Only with IL-12 present was there any increase in IFN     
  production from T cells, with the most substantial increase 
  occurring in the presence of both dll4 and IL-12. Although 
dll4 did little to signifi  cantly alter the response of wild-type T 
cells by itself, the combination of this signal with IL-12 again 
led to a signifi  cant reduction of Th2 cytokines and increased 
production of IFN    . These data suggest that both of these 
signals are necessary for the strongest Th1 response. Altogether, 
these studies allow signifi  cant insight into the potential mech-
anisms of how these two instructive signals work in collabo-
ration with one another. Together, the fi  ndings suggest that 
dll4 in combination with IL-12 can regulate both Th1 and 
Th2 cytokine production. 
  To verify that the addition of dll4 to cocultures of DC 
and T cells was activating Notch pathways, we examined 
HES1 expression by quantitative real-time PCR (  21  –  23  ). Cul-
tures receiving dll4 showed a 3.1   ±   0.28-fold increase in 
HES1 expression over cultures with DC and T cells alone. 
Together with the aforementioned data, these fi  ndings im-
plicate that dll4 is able to skew T cell maturation via Notch 
  signaling pathways. 
    DISCUSSION   
  Specifi  c adaptive immunity is regulated by the host response 
to individual pathogens and dictated by numerous immuno-
modulatory molecules. This is of particular importance because 
the diff  erentiation of CD4 into Th1 eff  ector cells mediates 
host immunity against viruses via development of cell-medi-
ated immunity. In general, a Th1 response is initiated by 
APCs that are stimulated via TLRs that recognize pathogen-
associated molecular patterns (  24  –  27  ). Specifi  c pathogen  –
    associated molecular patterns trigger the production of IL-12 
and induce the diff  erentiation of IFN    -producing Th1 cells, 
as well as viral-specifi  c Tc1 cells. Th2 responses tend to arise 
in response to pathogens in the absence of TLRs, leading 
many researchers to suggest that Th2 diff  erentiation is a de-
fault pathway that arises in the absence of IL-12. This is sup-
ported by studies that show MyD88    −  /  −    animals were incapable 
of generating Th1 responses (  28  ) and by studies using infec-
tious agents in MyD88    −  /  −    mice (  29  –  31  ). In addition, MyD88-
mediated signals appear to provide a regulatory signal for 
Th2-type responses (  28  ). Conversely, not all Th1-inducing 
pathogens default to Th2 responses in the absence of IL-12 (  32  ). 
This suggests that other signals may exist on APCs to elicit a 
Th1 response. Recent studies suggest that the Notch ligands 
  Figure 6.     IL-12 and dll4 differentially alter the cytokine profi  le of 
MyD88    −  /  −    T cells restimulated with RSV. CD4  +   T cells were isolated 
from MyD88   − / −    mice 9 d after RSV infection and restimulated with 
MyD88   − / −    DC for 48 h. Cytokines were assayed by a luminex system, as 
in   Fig. 5  . (A) IL-12 regulates IFN     production. *, P   <   0.05 compared 
with control and dll4-treated wells. (B) Dll4 regulates IL-13 production. 
*, P   <   0.05 compared with control. **, P   <   0.01 compared with control 
cultures and those containing IL-12. (C) IL-4 cytokine production in the same 
cultures. #, P   <   0.05 compared with control; *, P   <   0.01 compared with 
control; **, P   <   0.001 compared with control, and P   <   0.05 compared 
with cultured with IL-12 or dll4 alone. Error bars represent the mean   ±   
the  SEM.   JEM VOL. 204, November 26, 2007 
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Notch signaling protein RBPJ     can bind to a promoter re-
gion of GATA3 (  42, 43  ). Furthermore, these studies demon-
strate that the absence of the Notch signaling pathway impairs 
the ability of T cells to diff  erentiate to a Th2 lineage. Although 
our data do not corroborate these latter observations, they do 
suggest that not all Notch signals are activating. Instead, some 
Notch signals may be regulatory in nature for specifi  c genes 
in T cells that contain a functioning Notch signaling pathway. 
In addition, the outcome of Notch activation may also de-
pend on the diff  erentiation state of the T cell and the specifi  c 
immune environment in which it receives Notch signals. 
In fact,   dll4   has been described to specifi  cally skew T cells to 
a Th1 phenotype upon initial activation. 
  In further support of the contention that Notch signals 
may be regulatory to certain genes, analysis of isolated CD4  +   
T cells that had been restimulated with RSV indicated that 
one role for dll4 was to suppress Th2 cytokine production. 
Several previous studies have identifi  ed other factors that 
are responsible for diff  erentiation of T cells, such as specifi  c 
costimulatory molecule use or IL-12 versus -10 production 
by APCs (  24, 44, 45  ). Our previous studies with anti  –  IL-12 
treatment during RSV infection demonstrated a signifi  cant 
reduction in IFN    , along with increases in eosinophils and 
mucus overexpression. The development of AHR in the anti  –
  IL-12  –  treated animals may result from an altered immune 
environment caused by a diff  erent mechanism, such as down-
regulation of IFN    , but leading to a similar physiologic end-
point as a blockade of dll4. The data outlined in these studies 
begin to defi  ne how Notch ligands can participate in concert 
with other factors, such as IL-12, to shape the immune re-
sponse by regulating specifi  c aspects of T cell activation. 
However, it is not entirely clear in our studies whether 
the development of the Th2 response is merely caused by 
the blockade of   dll4  , which directly aff  ects Th2 cytokine pro-
duction, or whether there was an up-regulation of other 
Th2-instructive signals that, until now, have been relatively 
undefi  ned. The role of IL-13 on development of Th2 re-
sponses has been well established in multiple studies (  46, 47  ), 
and it appears that   dll4   expression on DCs is at least part 
of the mechanism that controls IL-13 production from CD4  +   
T cells. Although   GATA3   activation is required for Notch1-
induced Th2 cytokine activation (  11  ), recent studies have 
highlighted that other binding elements are also important, 
such as the recently described   CNS-2   that regulates Notch-
induced Th2 cytokines in NK and memory T cells (  48  ). 
These latter studies indicated that Notch and RBPJ activation 
regulate initial Th2 cytokine production, whereas STAT6 is 
necessary for secondary Th2 cytokine expression. Interest-
ingly, deletion of GATA3 before primary activation of naive 
T cells diminished both IL-4-dependent and IL-4  –  indepen-
dent Th2 diff  erentiation, whereas deletion of GATA3 in 
  established Th2 cells only reduced IL-5 and -13, but not IL-4 
production (  49  ). These latter results may best refl  ect our data 
with   dll4  -mediated regulation in RSV-induced responses, 
suggesting that perhaps   dll4   activation of Notch regulates 
critical transcription factors during RSV infection. Overall, 
dll and jagged can provide previously unknown instructional 
signals for the development of Th1 and Th2 cells, respec-
tively (  1  ). However, little research has investigated the role 
of Notch  –  Notch ligand system in acquired viral immunity, 
and the requirement of Notch activation in development of 
Th1 and/or Th2 responses is still unclear. Importantly, dll4 
was the primary Notch ligand up-regulated on BMDCs 
grown in culture after RSV infection (  18  ). The data in these 
studies clearly identify a critical role for dll4 for the develop-
ment of a Th1-mediated response, along with the require-
ment for IL-12 to optimally drive the production of IFN    . 
  Notch activation has been identifi  ed as an important sig-
naling molecule in many cell populations, and regulates a 
wide variety of cell diff  erentiation and proliferation parameters 
(  4, 5, 33, 34  ). In the thymus, Notch and its ligands have been 
shown to be important in allowing DN T cell progenitors to 
mature to double-positive T cells (CD4/CD8), although the 
exact Notch receptor  –  ligand interactions are still not com-
pletely clear at each of the DN T cell stages (  3, 6, 9, 10  ). The 
data in this study indicate that   dll4   neutralization in vivo 
during RSV infection increased Th2 cytokine production. 
In addition, neutralization of   dll4   during RSV infection 
  altered CD4 and CD8 T cell accumulation and activation 
responses within the lung. Specifi  cally, the increased CD4  +   
T cells in the lungs of anti-  dll4    –  treated animals correlated 
with the changing cytokine profi  le toward increased Th2 
type cytokines, as it is the CD4  +   T cell population that pri-
marily produces Th2 cytokines during RSV infection (un-
published data) (  35  –  37  ). In vivo studies examined param  eters 
associated with RSV-induced disease in infants, including 
airway hyperreactivity, mucus production, and goblet cell 
hyperplasia, and demonstrated a heightened pathogenic eff  ect 
when   dll4   was blocked. Numerous studies have previously 
examined these endpoints and found that they corre  spond to 
and depend on IL-13 production (  38  –  41  ). The data in these 
studies suggest that the increased pathogenesis observed dur-
ing   dll4   blockade of RSV-infected mice appears to be asso-
ciated with altered CD4  +   T cell activation and not decreased 
viral clearance or CD8  +   T cell activation. These data corre-
spond well to earlier publications, demonstrating that diff  er-
ent Notch ligands drive maturation of CD4  +   T cells (  11  ). 
However, the mechanism of how Notch regulates mature T 
cell diff  erentiation is not yet clear. Although studies have 
demonstrated that individual Notch ligands can infl  uence 
the direction of the T cell response, other studies using ge-
netically manipulated mice have shown that Notch is re-
quired for Th2, but not Th1, cell development (  11, 15  ). 
In the latter study, it may be that other Th1 signals, such as 
IL-12, may be able to compensate for the lack of Notch1, 
whereas Th2 development requires Notch1 signaling through 
alternative ligands, such as Jagged1. The requirement of 
Notch activation for Th2 development has more recently 
been validated in two independent studies using mice with 
defects in the Notch signaling pathway. The experiments 
performed assessed the role of Notch signaling in respect 
to the regulation of GATA3 expression and found that the 2932 DELTA-LIKE 4 IN RESPIRATORY VIRAL INFECTION | Schaller et al.
and cells were plated overnight. The next day, DCs were infected with RSV 
(MOI = 1.0) for the indicated times. 
  In vitro CD4  +   T cell treatments.     Magnetic bead isolated CD4  +   lymph 
node T cells were obtained on day 8 after RSV infection using the MACS 
system. Lymph node cells were fi  ltered through nylon mesh and depleted 
of erythrocytes with lysis buff  er, and CD4  +   T cells were isolated using 
anti-CD4  +   magnetic beads (Miltenyi Biotec). For DC T cell cocultures, 
BMDCs were fi  rst plated in a fl  at-bottom 96-well plate and infected with 
RSV for 2 h. BMDCs were washed and resuspended in fresh media. CD4  +   
T cells from RSV-infected mice were added to wells at a DC:CD4  +   cell 
ratio of 1:20, and supernatants were harvested 48 h later for cytokine 
pro  tein analysis. 
  Flow cytometric analysis.     Lung cells were isolated after collagenase dis-
persion to obtain single-cell suspensions, as previously described (  54  ), and 
lymph node cells were isolated as previously described. Cells were stained 
with the indicated antibodies after 5 min of preincubation with FC block 
(BD Biosciences), fi  xed overnight with 4% formalin, and run on a Cytomics 
FC-500 (Beckman Coulter). Samples were analyzed using FlowJo software 
(Tree Star, Inc.). 
  Statistics.     Statistical signifi  cance was determined by analysis of variance 
with a Student  ’  s Neuman Kuhl posttest, where relevant. Values of P   <   0.05 
were considered signifi  cant. In cases where two groups were being com-
pared, a Student  ’  s   t   test was performed to determine signifi  cance; P   ≤   0.05 
was considered signifi  cant. 
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carefully in future experiments. 
  The impact of these responses related to   dll4   are defi  ning 
for viral responses in the lung, as the data in this study indicate 
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